英克西兰
生产厂家：瑞士诺华制药
功能主治：高胆固醇血症或血脂异常，降低低密度脂蛋白胆固醇
用法用量：用法用量 皮下注射给药，在第0、3个月各给药一次后，维持期每6个月给药一次，一年只需注射2次。 给药方法：皮下注射使用：Leqvio(inclisiran)用于腹部皮下注射;替代注射部位包括上臂或大腿。 不应在活动性皮肤病或损伤部位注射，如晒伤、皮疹、炎症或皮肤感染。 1.在给药前，应该对Leqvio(inclisiran)进行目视检查。 溶液应该是透明、无色到淡黄色，基本上没有微粒。 如果溶液中含有可见的颗粒物，则不应使用该溶液。 2.每个284mg剂量使用一个单一的预充注射器;每个预充注射器仅供一次性使用。 本品仅由专业的医护人员管理和使用。 错过剂量：(1)如果错过计划剂量少于3个月，应及时给予Leqvio，并按照患者原来的计划继续给药。 (2)如果错过计划剂量超过3个月，则应开始新的给药方案——在第0、3个月各给药一次后，维持期每6个月给药一次。 从使用单克隆抗体PCSK9抑制剂治疗过渡到本品：可以在最后一次使用单克隆抗体PCSK9抑制剂后立即使用本品。 为了维持较低的LDL-C，建议在最后一次使用单克隆抗体PCSK9抑制剂后2周内给予本品。
查看详情
Despite its effectiveness, accessing Inclisiran in some countries can be challenging. Regulatory processes and approval delays can limit the availability of this medication. As a result, patients looking for an immediate solution to their high cholesterol levels often turn to overseas Inclisiran purchasing. This is facilitated through various channels, including online platforms or specialized agencies that help individuals navigate the complex process of procuring the medication from abroad.
The allure of overseas Inclisiran purchasing lies in its potential to provide ease of access and cost advantages. Countries where Inclisiran is readily available and approved may be able to offer the medication at a lower price compared to nations with more stringent regulations. Patients can avail themselves of the opportunity to obtain this medication without the wait time associated with local regulatory processes.However, it is important to exercise caution when considering overseas Inclisiran purchasing. There are potential risks and challenges involved in obtaining medication from abroad. Firstly, there may be uncertainty regarding the authenticity and quality of products purchased through unofficial channels. Counterfeit medication is a real concern, as it can have serious health implications and may not deliver the desired therapeutic effect.
Additionally, there may be legal implications associated with importing medication without appropriate authorization. Each country has its own laws and regulations governing the importation of pharmaceutical products, and it is crucial to be aware of these before engaging in overseas purchasing. Violating these laws can result in legal consequences, leading to further complications and potential health risks.
Therefore, it is advisable for individuals considering overseas Inclisiran purchasing to consult with healthcare professionals and consider official channels for importation. This ensures access to authentic medication that meets quality standards and legal requirements. While the process may require patience and navigating bureaucratic processes, it ultimately provides a safer and reliable way to obtain the necessary medication.
In conclusion, the rise in popularity of Inclisiran as a treatment for hypercholesterolemia or dyslipidemia has given rise to a trend of overseas purchasing. While this may offer potential benefits in terms of ease of access and cost advantages, it is vital to exercise caution and be aware of the potential risks and challenges. Engaging with healthcare professionals and official channels is the recommended approach to ensure the procurement of authentic, high-quality medication while complying with legal requirements.
